Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.18
+0.23 (2.10%)
Mar 6, 2026, 4:00 PM EST - Market closed
Korro Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 7.37 | 2.27 | - | - | - |
| Gross Profit | 0.05 | 2.27 | - | - | - |
| Selling, General & Admin | 41.16 | 41.87 | 36.54 | 21.39 | 14.06 |
| Research & Development | 53.39 | 52.31 | 48 | 37.61 | 21.43 |
| Operating Expenses | 94.55 | 94.18 | 84.53 | 59 | 35.49 |
| Operating Income | -94.5 | -91.91 | -84.53 | -59 | -35.49 |
| Other Non Operating Income (Expenses) | 6.19 | 8.47 | 3.39 | 0.98 | 13.54 |
| Pretax Income | -88.31 | -83.44 | -81.15 | -58.02 | -21.96 |
| Income Tax Expense | 0.1 | 0.14 | 0.03 | 0.01 | 0 |
| Net Income | -88.42 | -83.58 | -81.17 | -58.03 | -21.96 |
| Net Income to Common | -88.42 | -83.58 | -81.17 | -58.03 | -21.96 |
| Shares Outstanding (Basic) | 9 | 9 | 2 | 0 | 4 |
| Shares Outstanding (Diluted) | 9 | 9 | 2 | 0 | 4 |
| Shares Change (YoY) | 18.78% | 483.30% | 499.32% | -94.26% | - |
| EPS (Basic) | -9.42 | -9.37 | -53.08 | -227.42 | -4.94 |
| EPS (Diluted) | -9.42 | -9.37 | -53.08 | -227.42 | -4.94 |
| Free Cash Flow | -70.24 | -77.98 | -75.12 | -58.86 | -36.54 |
| Free Cash Flow Per Share | -7.49 | -8.74 | -49.12 | -230.65 | -8.22 |
| Gross Margin | 0.62% | 100.00% | - | - | - |
| Operating Margin | -1282.04% | -4047.12% | - | - | - |
| Profit Margin | -1199.53% | -3680.36% | - | - | - |
| Free Cash Flow Margin | -952.92% | -3433.55% | - | - | - |
| EBITDA | -89.62 | -88.35 | -80.9 | -56.49 | -33.9 |
| D&A For EBITDA | 4.88 | 3.57 | 3.63 | 2.51 | 1.6 |
| EBIT | -94.5 | -91.91 | -84.53 | -59 | -35.49 |
Source: S&P Capital IQ. Standard template.
Financial Sources.